Reaction

Fine Motor Skill Dysfunction reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,844 reports · 85 co-occurring drugs

As of the last recalculation, Fine Motor Skill Dysfunction appears in 2,844 FAERS reports alongside 85 co-occurring drug terms. The strongest observed disproportionality signal is ANAKINRA (PRR 44.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Anakinra	97	44.3	44.5
Valproate Sodium	80	29.1	29.2
Ketoprofen	35	19.8	19.8
Hydroxychloroquine Sulfate	210	18.1	18.2
Sulfasalazine	156	15.4	15.4
Leflunomide	191	14.2	14.3
Losartan Potassium And Hydrochlorothiazide	22	14.0	14.0
Abatacept	236	13.5	13.5
Tocilizumab	197	13.5	13.5
Hydroxychloroquine	131	13.4	13.4
Pramipexole	26	12.5	12.5
Siponimod	15	12.4	12.4
Human Immunoglobulin G	34	12.2	12.2
Levodopa	18	11.0	11.0
Amantadine	23	11.0	11.0
Rotigotine	21	10.7	10.7
Indomethacin	19	10.6	10.6
Golimumab	115	10.2	10.2
Tranexamic Acid	12	9.9	9.9
Dalfampridine	89	9.3	9.4
Carbidopa And Levodopa	59	9.3	9.3
Certolizumab Pegol	134	8.7	8.7
Teriflunomide	53	8.7	8.7
Phytonadione	10	8.7	8.7
Ocrelizumab	71	8.6	8.6
Rivastigmine	21	8.2	8.2
Minocycline	13	8.2	8.2
Rosuvastatin Calcium	29	7.6	7.6
Tofacitinib	181	7.6	7.6
Methotrexate Sodium	423	7.3	7.3
Rituximab	192	7.1	7.1
Methotrexate	359	7.0	7.0
Lamotirigine	67	7.0	7.0
Lamotrigine Extended-Release	67	7.0	7.0
Lamotrigine Chewable Dispersible	67	7.0	7.0
Cladribine	9	6.9	6.9
Alemtuzumab	18	6.8	6.9
Progesterone	21	6.8	6.8
Rasagiline Mesylate	10	6.6	6.6
Cyclobenzaprine Hydrochloride	8	6.5	6.5
Lithium Carbonate	15	6.5	6.5
Cyclobenzaprine	43	6.4	6.4
Ropinirole	13	6.2	6.2
Celecoxib	107	6.1	6.1
Baricitinib	8	6.1	6.1
Naproxen	64	6.1	6.1
Ofatumumab	27	6.0	6.0
Bupropion	36	6.0	6.0
Oxazepam	17	5.8	5.8
Terazosin Hydrochloride	7	5.8	5.8
Fingolimod Hcl	66	5.7	5.7
Tofacitinib Citrate	10	5.6	5.6
Infliximab	158	5.5	5.6
Biotin	23	5.4	5.4
Glatiramer Acetate	43	5.3	5.3
Etanercept	368	5.0	5.0
Citalopram Hydrobromide	72	5.0	5.0
Baclofen	58	5.0	5.0
Diroximel Fumarate	8	4.9	4.9
Dorzolamide Hydrochloride And Timolol Maleate	5	4.6	4.6
Desoximetasone	12	4.6	4.6
Pimavanserin Tartrate	34	4.5	4.5
Medroxyprogesterone Acetate	29	4.3	4.3
Botulinum Toxin Type A	7	4.1	4.1
Peginterferon Beta-1A	7	3.9	3.9
Dimethyl Fumarate	61	3.7	3.7
Asfotase Alfa	5	3.7	3.7
Adalimumab	315	3.5	3.5
Treprostinil	59	3.5	3.5
Interferon Beta-1B	9	3.4	3.4
Testosterone Cypionate	4	3.3	3.3
Insulin Lispro	56	3.0	3.0
Temozolomide	8	2.8	2.8
Interferon Beta-1A	71	2.7	2.7
Ravulizumab	5	2.7	2.7
Naltrexone Hydrochloride And Bupropion Hydrochloride	3	2.6	2.6
Droxidopa	7	2.4	2.4
Axicabtagene Ciloleucel	3	2.2	2.2
Onabotulinumtoxina	23	2.2	2.2
Natalizumab	46	1.9	1.9
Lifitegrast	4	1.8	1.8
Vigabatrin	3	1.5	1.5
Alirocumab	5	1.5	1.5
Valbenazine	5	1.5	1.5
Apremilast	24	1.2	1.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.